GlucoTrack, Inc. (NASDAQ:GCTK) Short Interest Update

GlucoTrack, Inc. (NASDAQ:GCTK) saw a large increase in short interest during the month of July. As of July 15th, there was short interest totaling 2,388,682 shares, an increase of 368.1% from the June 30th total of 510,338 shares. Currently, 31.7% of the company’s stock are short sold. Based on an average daily trading volume, of 11,948,792 shares, the short-interest ratio is currently 0.2 days.

GlucoTrack Stock Down 6.8%

Shares of GCTK stock traded down $0.02 during mid-day trading on Friday, reaching $0.29. 273,849 shares of the company were exchanged, compared to its average volume of 8,697,584. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.85 and a current ratio of 0.85. The business’s 50 day simple moving average is $0.45 and its 200 day simple moving average is $1.24. The company has a market capitalization of $2.25 million, a P/E ratio of -0.02 and a beta of 0.77. GlucoTrack has a fifty-two week low of $0.29 and a fifty-two week high of $14.14.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Wall Street Zen lowered GlucoTrack to a “strong sell” rating in a research report on Saturday, July 18th. Weiss Ratings reissued a “sell (e+)” rating on shares of GlucoTrack in a report on Friday, July 17th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, GlucoTrack currently has an average rating of “Sell”.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in GCTK. Ikarian Capital LLC bought a new stake in shares of GlucoTrack in the 4th quarter worth about $177,000. Boothbay Fund Management LLC acquired a new stake in shares of GlucoTrack in the 4th quarter valued at about $52,000. Finally, Bank of America Corp DE lifted its position in shares of GlucoTrack by 102,125.0% during the second quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after purchasing an additional 4,085 shares during the last quarter. 10.92% of the stock is currently owned by institutional investors.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.